Secondary Prevention of Hyperkalemia With Sodium Polystyrene Sulfonate in Cardiac and Kidney Patients on Renin‐Angiotensin‐Aldosterone System Inhibition Therapy

BACKGROUND: Hyperkalemia, induced by renin‐angiotensin‐aldosterone system inhibition (RAAS‐I) in patients with chronic kidney disease (CKD), or cardiac disease often leads to withdrawal of RAAS‐I therapy. Sodium polystyrene sulfonate (SPS) is a potassium‐binding resin used for the treatment of hyper...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Cardiol
Autores principales: Chernin, Gil, Gal‐Oz, Amir, Ben‐Assa, Eyal, Schwartz, Idit F., Weinstein, Talia, Schwartz, Doron, Silverberg, Donald S.
Formato: Artigo
Lenguaje:Inglês
Publicado: Wiley Periodicals, Inc. 2011
Materias:
Clinical Investigations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6652546/
https://ncbi.nlm.nih.gov/pubmed/22057933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20987
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares